Merck forms strategic alliance with R-Pharm for Russian government contracts
1 report, 1 independent
Updated Sun 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Merck established a strategic alliance with R-Pharm on November 1, 2026. The pharmaceutical company sells its anticancer drug Keytruda to the Russian government through R-Pharm, which is run by Alexey Repik, an oligarch close to Russian President Vladimir Putin. R-Pharm has previously faced scrutiny from Russia’s Federal Antimonopoly Service regarding coordinated bidding with other medicine distributors.
From icij.org
Why it matters
The alliance involves Merck selling a blockbuster drug to the Russian government via a company linked to a sanctioned oligarch. This structure raises questions regarding compliance and geopolitical risk associated with the sale of pharmaceutical products.
From icij.org
Who's involved
- MerckPharmaceutical company that forged the strategic alliance
Keep exploring
The entities involved
-
Merck
public company in Indonesia